Login / Register
MS Validated Antibodies - Logo
  • About us
  • Products
    • Primary antibodies
    • Gallery
  • Distributors
  • Validation
    • Tissue Microarrays
  • Publications
    • Large Scale Studies
    • Further Publications
    • Events
    • Quiz
  • Contact
  • About us
  • Products
    • Primary antibodies
    • Gallery
  • Distributors
  • Validation
    • Tissue Microarrays
  • Publications
    • Large Scale Studies
    • Further Publications
    • Events
    • Quiz
  • Contact
×

Cancer Tissue Gallery Androgen Receptor

Path Created with Sketch.
Go to Androgen Receptor Normal Tissue GalleryGo back to Product Page
Adrenal gland - AR negative adrenocortical adenoma.
Adrenal gland – AR negative adrenocortical adenoma.
Breast - Invasive breast cancer of no special type (NST) with moderate to strong AR immunostaining of tumor cells.
Breast – Invasive breast cancer of no special type (NST) with moderate to strong AR immunostaining of tumor cells.
Breast - Invasive lobular breast cancer with strong AR immunostaining of tumor cells.
Breast – Invasive lobular breast cancer with strong AR immunostaining of tumor cells.
Colon - AR negative colorectal adenocarcinoma.
Colon – AR negative colorectal adenocarcinoma.
Esophagus - AR negative adenocarcinoma.
Esophagus – AR negative adenocarcinoma.
Esophagus - AR negative squamous cell carcinoma.
Esophagus – AR negative squamous cell carcinoma.
Kidney - AR negative clear cell renal cell carcinoma.
Kidney – AR negative clear cell renal cell carcinoma.
Kidney - AR negative oncocytoma.
Kidney – AR negative oncocytoma.
Kidney - Papillary renal cell carcinoma with moderate to strong AR immunostaining of tumor cells.
Kidney – Papillary renal cell carcinoma with moderate to strong AR immunostaining of tumor cells.
Liver - AR negative cholangiocellular carcinoma.
Liver – AR negative cholangiocellular carcinoma.
Liver - Hepatocellular carcinoma with moderate to strong AR immunostaining of tumor cells.
Liver – Hepatocellular carcinoma with moderate to strong AR immunostaining of tumor cells.
Lung - AR negative adenocarcinoma.
Lung – AR negative adenocarcinoma.
Ovary - AR negative clear cell carcinoma.
Ovary – AR negative clear cell carcinoma.
Ovary - Serous high-grade carcinoma with moderate AR immunostaining of tumor cells.
Ovary – Serous high-grade carcinoma with moderate AR immunostaining of tumor cells.
Pancreas - AR negative ductal adenocarcinoma.
Pancreas – AR negative ductal adenocarcinoma.
Pancreas - AR negative neuroendocrine tumor.
Pancreas – AR negative neuroendocrine tumor.
Pharynx - AR negative squamous cell carcinoma.
Pharynx – AR negative squamous cell carcinoma.
Prostate - Adenocarcinoma (Gleason 4+4=8) showing strong AR immunostaining of tumor cells. Of note: AR staining is weaker in one residual normal prostate gland.
Prostate – Adenocarcinoma (Gleason 4+4=8) showing strong AR immunostaining of tumor cells. Of note: AR staining is weaker in one residual normal prostate gland.
Prostate - Adenocarcinoma (Gleason 4+4=8) with strong AR immunostaining.
Prostate – Adenocarcinoma (Gleason 4+4=8) with strong AR immunostaining.
Prostate - Adenocarcinoma (Gleason 5+5=10) with strong nuclear and cytoplasmic AR immunostaining of tumor cells.
Prostate – Adenocarcinoma (Gleason 5+5=10) with strong nuclear and cytoplasmic AR immunostaining of tumor cells.
Prostate - Recurrent adenocarcinoma of the prostate (Gleason 5+4=9) with subtotal loss of AR expression after castration therapy.
Prostate – Recurrent adenocarcinoma of the prostate (Gleason 5+4=9) with subtotal loss of AR expression after castration therapy.
Prostate - Small cell carcinoma with focal weak to moderate AR immunostaining of tumor cells.
Prostate – Small cell carcinoma with focal weak to moderate AR immunostaining of tumor cells.
Soft tissue - AR negative leiomyosarcoma.
Soft tissue – AR negative leiomyosarcoma.
Stomach - AR negative gastric adenocarcinoma (diffuse type).
Stomach – AR negative gastric adenocarcinoma (diffuse type).
Stomach - AR negative gastric adenocarcinoma.
Stomach – AR negative gastric adenocarcinoma.
Stomach - AR negative gastrointestinal stromal tumor (GIST).
Stomach – AR negative gastrointestinal stromal tumor (GIST).
Testis - AR negative seminoma.
Testis – AR negative seminoma.
Thorax - AR negative epitheloid malignant mesothelioma.
Thorax – AR negative epitheloid malignant mesothelioma.
Thyroid - AR negative medullary carcinoma.
Thyroid – AR negative medullary carcinoma.
Thyroid - AR negative papillary cancer.
Thyroid – AR negative papillary cancer.
Urinary bladder - Muscle-invasive urothelial carcinoma with focal weak AR immunostaining in <10% of tumor cells.
Urinary bladder – Muscle-invasive urothelial carcinoma with focal weak AR immunostaining in <10% of tumor cells.
Urinary bladder - Muscle-invasive urothelial carcinoma with moderate to strong AR immunostaining of tumor cells.
Urinary bladder – Muscle-invasive urothelial carcinoma with moderate to strong AR immunostaining of tumor cells.
Uterus - Endometroid endometrium carcinoma with AR immunostaining of variable intensity in the majority of tumor cells.
Uterus – Endometroid endometrium carcinoma with AR immunostaining of variable intensity in the majority of tumor cells.
  • Linkedin
  • My Account
  • Search
    ×
  • Cart 0
© 2025 MS Validated Antibodies
  • Imprint
  • Privacy Policy
  • Distributors